In English | En español
Questions About Cancer? 1-800-4-CANCER

NCI Drug Dictionary

  

NA17-A antigen 
A specific melanoma antigen protein derived from a patient (NA17) with cutaneous melanoma metastases. When administered in a vaccine formulation, NA17-A antigen may stimulate a cytotoxic T lymphocyte (CTL) response against tumors that express this antigen, which may result in a reduction in tumor size. The NA17-A antigen is part of the enzyme N-acetyl glucosaminyl-transferase V (GnT-V). Approximately half of melanomas have been found to express significant levels of this atypical protein, which is not expressed by normal tissues. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonym:NA17-A